Compounds > cryptotanshinone
Page last updated: 2024-09-04

cryptotanshinone and moxifloxacin

cryptotanshinone has been researched along with moxifloxacin in 1 studies

Compound Research Comparison

Studies
(cryptotanshinone)		Trials
(cryptotanshinone)		Recent Studies (post-2010)
(cryptotanshinone)		Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010) (moxifloxacin)
37002683,1575521,690

Protein Interaction Comparison

ProteinTaxonomycryptotanshinone (IC50)moxifloxacin (IC50)
DNA gyrase subunit BStaphylococcus aureus5.1033
DNA gyrase subunit AEscherichia coli K-121.4
DNA gyrase subunit BEscherichia coli K-121.4
DNA topoisomerase 4 subunit AStaphylococcus aureus0.8
DNA gyrase subunit AStaphylococcus aureus7.25
DNA gyrase subunit BMycobacterium tuberculosis H37Rv8.525
DNA gyrase subunit AMycobacterium tuberculosis H37Rv8.66

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

1 other study(ies) available for cryptotanshinone and moxifloxacin

ArticleYear
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021